Resistance after single-dose nevirapine prophylaxis emerges in a high proportion of Malawian newborns.
Eshleman, Susan H; Hoover, Donald R; Chen, Shu; Hudelson, Sarah E; Guay, Laura A; Mwatha, Anthony; Fiscus, Susan A; Mmiro, Francis; Musoke, Philippa; Jackson, J Brooks; Kumwenda, Newton; Taha, Taha.
; 19(18): 2167-9, 2005 Dec 02.
Artigo em Inglês | MEDLINE | ID: mdl-16284468
Optimisation of antiretroviral therapy in HIV-infected children under 3 years of age.
Effectiveness of antiretroviral therapy in HIV-infected children under 2 years of age.
Vitamin A supplements for reducing mother-to-child HIV transmission.
Clonal amplification and maternal-infant transmission of nevirapine-resistant HIV-1 variants in breast milk following single-dose nevirapine prophylaxis.
Complex immune correlates of protection in HIV-1 vaccine efficacy trials.
Integrating prevention of mother-to-child HIV transmission (PMTCT) programmes with other health services for preventing HIV infection and improving HIV outcomes in developing countries.
Maternal and infant antiretroviral regimens to prevent postnatal HIV-1 transmission: 48-week follow-up of the BAN randomised controlled trial.
Nevirapine resistance by timing of HIV type 1 infection in infants treated with single-dose nevirapine.
A post-partum single-dose TDF/FTC tail does not prevent the selection of NNRTI resistance in women receiving pre-partum ZDV and intrapartum single-dose nevirapine to prevent mother-to- child HIV-1 transmission.
Effect of 7 days of phenytoin on the pharmacokinetics of and the development of resistance to single-dose nevirapine for perinatal HIV prevention: a randomized pilot trial.